• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of the alkylating agent targeting intrahepatic cholangiocarcinoma -specific fusion gene

Research Project

Project/Area Number 16K10583
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Digestive surgery
Research InstitutionNihon University

Principal Investigator

TAKAGI Keiko  日本大学, 医学部, 研究医員 (20339328)

Co-Investigator(Kenkyū-buntansha) 緑川 泰  日本大学, 医学部, 准教授 (10292905)
尾崎 俊文  千葉県がんセンター(研究所), 発がん研究グループ DNA損傷シグナル研究室, 室長 (40260252)
藤原 恭子  日本大学, 歯学部, 准教授 (40595708)
Project Period (FY) 2016-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords肝内胆管癌 / 融合遺伝子 / PIポリアミド / ChB-PIP / アルキル化剤
Outline of Final Research Achievements

We aimed to develop chlorambucil-PI polyamide (ChB-PIP), which alkylates a fusion gene specific for intrahepatic cholangiocarcinoma (ICC) and kills only cells contain the fusion gene. ChB-PIP was prepared by purification and analysis by high performance liquid chromatography (HPLC), and the synthesis of ChB-PIP that specifically binds to the fusion gene was confirmed by gel shift assay. Then, a transient expression strain was prepared for the ICC cell line. Next, in order to establish a stable strain, after transfection, selection was performed using G418 (Geneticin) to scale up the cells.In the fusion gene plasmid-introduced group, the gene expression level was higher than that in the control group, and it was confirmed that a stable strain was produced.

Academic Significance and Societal Importance of the Research Achievements

配列特異的にDNAに結合する性質を持つピロール・イミダゾール・ポリアミド(PIP)を用いて、融合領域を認識するPIPにアルキル化剤クロラムブシル(ChB)を付加したFGFR2-BICC1融合遺伝子認識ChB-PIPの合成を成功させた。また、融合遺伝子2種のいずれかの存在が確認されているICC細胞株が樹立されていないことから、安定株の作製を成功させた。

Report

(5 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (1 results)

All Other

All Remarks (1 results)

  • [Remarks] 肝内胆管癌特異的融合遺伝子を標的としたPIPの開発

    • URL

      http://www.med.nihon-u.ac.jp/research_institute/bulletin/

    • Related Report
      2017 Research-status Report 2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi